RAPT Therapeutics, Inc. Other Accrued Liabilities, Current
RAPT Therapeutics, Inc. had Other Accrued Liabilities, Current of $97.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Other Accrued Liabilities, Current $97.00K.
- 2025-06-30: Other Accrued Liabilities, Current $129.00K.
- 2025-03-31: Other Accrued Liabilities, Current $137.00K.
- 2024-12-31: Other Accrued Liabilities, Current $142.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $97.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $129.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $137.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $142.00K 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $168.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $126.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $203.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $178.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $156.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $185.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $236.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $238.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $173.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $127.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $117.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $54.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $39.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $40.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $64.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $263.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $60.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $164.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $196.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $318.00K 10-K · filed 2021-03-11 | $289.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $93.00K 10-Q · filed 2019-12-11 | |
| 2018-12-31 | $72.00K 10-K · filed 2020-03-30 |